Profile of Intravenous Admixture Compatibility in The Intensive Care Unit (ICU) Patients

Journal Title: Indonesian Journal of Clinical Pharmacy - Year 2016, Vol 5, Issue 2

Abstract

Compatibility is one of the important factors determining the quality of intravenous (IV) admixtures which may directly impact to the outcome of treatment to the Intensive Care Unit (ICU) patients. The objective of this study was to identify the profile of compatibility and incompatibility among IV admixtures given to the ICU patients. This observational research was conducted prospectively to the patients admitted in the ICU at a private hospital in Surabaya from October–December 2014. In this research, compatibility data of IV drug and its solution was compared with drug brochure and Handbook on Injectable Drugs 17th ed (2013) as references to analyze the compatibility of IV admixtures. The admixture between IV drug and its solvent was classified as compatible, incompatible, no information (NI), not applicable (NA), and not clear (NC), using a specific criteria. There were 1.186 IV drug-solvent admixtures observed in 39 ICU patients. There were no IV drug-solvent admixtures classified as incompatible in both adult and child patients. Most of IV drugs were admixed with compatible solvents (adults: 72.31%; children: 69.84%). However, according to two of IV drugs compatibility references used in this research, there were some IV drug-solvent admixtures with unknown information about its compatibility that were classified as NI (adults: 19.68%; children: 30.16%). There were a few of IV drug-solvent admixtures classified as NA and NC, of 7.48% and 0.53%, respectively. The lack of information related to compatibility and stability of the IV admixtures emphasize the importance to continually monitor patients’ condition and drug concentration.

Authors and Affiliations

Sharly Dwijayanti, Sylvi Irawati, Eko Setiawan

Keywords

Related Articles

Cancer Therapy with Radiation: The Basic Concept of Radiotherapy and Its Development in Indonesia

Cancer is one of the leading causes of death worldwide. According to WHO, 8,8 million deaths in 2015 was caused by cancer. In Indonesia, based on basic health research data in 2013, the prevalence of cancer was 1.4% or 3...

Heart-type Fatty Acid-Binding Protein (H-FABP) as a Biochemical Marker to Differentiate Ischemic and Hemorrhagic Stroke

Stroke is an acute neurological syndrome that occurs due to a decrease in blood flow caused by blocked or rupture of blood vessels of the brain (cerebrovascular) that causes damage to brain tissue. Based on the pathogene...

Association of Pattern of Bacteria Sensitivity During the Empirical Antibiotics Use to the Achievement of Clinical Outcome in Pediatric Patients with Pneumonia

Pneumonia is one of infectious diseases that require a comprehensive and effective effort in its treatment, including in the use of empirical antibiotics. The use of empirical antibiotics should be based on patterns of s...

Pharmacists’ Interventions in A Paediatric Haematology-Oncology Pharmacy: Do They Matter to Minimise Medication Misadventure?

Paediatric patients with cancer are a high-risk patient population for medication misadventures. This study aimed to document and evaluate the role of pharmacists’ interventions during dispensing-related activities in mi...

Stability of Seven Days Sample Storage of Erythrocyte’s SOD and Blood’s GPx

The research was about SOD erythrocyte activities at day 0, 1, 3, 5, and 7 which centrifuged at room temperature (22.5 0C) and storage temperature (-80 0C), SOD activities at day-0 which centrifuged at 4 0C, SOD whole b...

Download PDF file
  • EP ID EP365286
  • DOI 10.15416/ijcp.2016.5.2.84
  • Views 84
  • Downloads 0

How To Cite

Sharly Dwijayanti, Sylvi Irawati, Eko Setiawan (2016). Profile of Intravenous Admixture Compatibility in The Intensive Care Unit (ICU) Patients. Indonesian Journal of Clinical Pharmacy, 5(2), 84-97. https://europub.co.uk./articles/-A-365286